Stay updated on Uproleselan High Dose Combo in AML Clinical Trial
Sign up to get notified when there's something new on the Uproleselan High Dose Combo in AML Clinical Trial page.

Latest updates to the Uproleselan High Dose Combo in AML Clinical Trial page
- ChecktodayChange DetectedThe record history reflects a new update posted November 13, 2026, with changes to the study status and sponsor/collaborator sections. The history also lists version 47, submitted November 10, 2026.SummaryDifference0.3%

- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe site footer revision changed from v3.7.2 to v3.8.0.SummaryDifference0.1%

- Check21 days agoChange DetectedA site-wide NIH notice announces a transition from the term “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference0.4%

- Check28 days agoChange DetectedThe ClinicalTrials.gov footer now identifies the site as revision v3.7.2 instead of v3.7.1.SummaryDifference0.1%

- Check35 days agoChange DetectedThe ClinicalTrials.gov site footer now displays revision v3.7.1 instead of v3.7.0.SummaryDifference0.1%

- Check56 days agoChange DetectedA new revision entry v3.7.0 appears in the study record history, indicating an update to the record's revision history. The previous revision v3.6.6 is removed from the history.SummaryDifference0.1%

Stay in the know with updates to Uproleselan High Dose Combo in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Uproleselan High Dose Combo in AML Clinical Trial page.